News

7:30 AMYahoo Finance

BridgeBio to Present new acoramidis data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026

BBIO−1.8%

7:30 AMYahoo Finance

BridgeBio to Participate in November and December investor Conferences

BBIO−1.8%

4:01 PMYahoo Finance

BridgeBio Pharma reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BBIO−1.8%

7:30 AMYahoo Finance

BridgeBio to Present new acoramidis data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific sessions 2026

BBIO−1.8%

7:05 AMYahoo Finance

Should you Invest $1,000 in BridgeBio Pharma right now?

BBIO−1.8%

4:10 PMYahoo Finance

What is BridgeBio Pharma (BBIO) betting on with three FDA priority launches?

BBIO−1.8%

1:04 PMYahoo Finance

BridgeBio's Heart disorder Drug Attruby faces unanticipated near-term tailwinds, UBS says

BBIO−1.8%

8:30 AMYahoo Finance

BridgeBio Pharma, Inc. Q3 2026 earnings call summary

BBIO−1.8%

8:14 PMYahoo Finance

What BridgeBio Pharma (BBIO) said on its Q3 earnings call

BBIO−1.8%

4:30 PMYahoo Finance

BridgeBio Pharma (BBIO) Q3 earnings: Taking a look at key Metrics Versus estimates

BBIO−1.8%

4:10 PMYahoo Finance

BridgeBio Pharma (BBIO) reports Q3 loss, beats revenue estimates

BBIO−1.8%

4:07 PMYahoo Finance

BridgeBio Pharma: Q3 earnings snapshot

BBIO−1.8%